Effect of lentivirus mediated cyclooxygenase-2 gene shorthairpinRNA on invasiveness of endometrial carcinoma

Objective: This study aims to explore the effects of lentivirus mediated cyclooxygenase-2 gene shorthairpinRNA (COX-2-shRNA) on invasiveness of endometrial carcinoma HEC-1B cells. Materials and Methods: Double-stranded DNA oligonucleotide of COX-2-shRNA was designed and synthesized, and the recombinant lentiviral vector COX-2-ShRNA (LV-COX-2-ShRNA) was constructed. LVCOX-2-ShRNA, pHelper 1, and pHelper 2 were transferred into 293T cells, followed by lentiviral packaging. The virus titer was tested according to expression level of GFP in 293T cells. HEC-1B cells were infected with recombinant lentivirus. The silencing of COX-2 gene was assessed by rea1-time PCR and western-blot, and the in vivo invasiveness of HEC-1B cells was analyzed by transwell invasion assay. Results: Recombinant lentiviral vector expressing siRNA targeting COX-2 gene was successfully constructed to harvest the recombinant lentivirus with the concentrated virus suspension titer of 5×l07Tu/ml. Compared with control group, the inhibitory rate of COX-2 expression in HEC-1B cells in siRNA group were 61.87% and 67.48% at mRNA and protein level, respectively. The mean number of cells penetrating matrigel was 16.6, which was significantly less than the control group 50.2 and non-specific siRNA infection group 47.2, the invasion inhibition rate being 64.8% (p < 0.01). Conclusion: RNA interference can inhibit the invasiveness of HEC-1B cells.

RNA interference; Cyclooxygenase-2; Endometrial carcinoma.

[1] Charames G.S., Bapat B.: “Cyclooxygenase-2 knockdown by RNA interference in colon cancer”. Int. J. Oncol., 2006, 28, 543.

[2] Xiao Y., Teng Y., Zhang R., Luo L.: “Antitumor effect of the selective COX-2 inhibitor celecoxib on endometrial adenocarcinoma in vitro and in vivo”. Oncology Letters, 2012, 6, 1219.

[3] Kobayashi S., Sakatani M., Kobayashi S., Okuda K., Takahashi M.: “Gene silencing of cyclooxygenase-2 mRNA by RNA interference in bovine cumulus-granulosa cells”. J. Reprod. Dev., 2007, 53, 1305.

[4] Jiang G., Li T., Qiu Y., Rui Y., Chen W., Lou Y.: “RNA interference for HIF-1alpha inhibits foam cells formation in vitro”. Eur. J. Pharmacol., 2007, 562, 183.

[5] Narayanan B.A., Narayanan N.K., Davis L., Nargi D.: “RNA interference- mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor”. Mol. Cancer Ther., 2006, 5, 1117.

[6] Strillacci A., Griffoni C., Spisni E., Manara M.C., Tomasi V.: “RNA interference as a key to knockdown overexpressed cyclooxygenase- 2 gene in tumour cells”. Br. J. Cancer, 2006, 94, 1300.

[7] Li X., Wang X., Yang Y., Xu C., Shen H.: “RNA interference targeting CHFR enhances taxol chemosensitivity in endometrial cancer cells”. Oncol. Rep., 2012, 28, 248.

[8] Chen W., Zhang H., Wang J., Cao G., Dong Z., Su H., et al.: “Lentiviral-mediated gene silencing of Notch-4 inhibits in vitro proliferation and perineural invasion of ACC-M cells”. Oncol. Rep., 2013, 29, 1797.

[9] Song C., Zhou X., Dong Q., Fan R., Wu G., Ji B., et al.: “Regulation of inflammatory response in human chondrocytes by lentiviral mediated RNA interference against S100A10”. Inflamm. Res., 2012, 61, 1219.

[10] Abbas-Terki T., Blanco-Bose W., Déglon N., Pralong W., Aebischer P.: “Lentiviral-mediated RNA interference”. Hum. Gene Ther., 2002,13, 2197.

[11] Singh B., Berry J.A., Vincent L.E., Lucci A.: “Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer”. J. Surg. Res., 2006, 134, 44.

[12] Ogino S., Kirkner G.J., Nosho K., Irahara N., Kure S., Shima K., et al.: “Cyclooxygenase-2 expression is an independent predictor ofpoor prognosis in colon cancer”. Clin. Cancer Res., 2008, 14, 8221.

[13] Zhao G.Q., Du Z.D., Liang T., Liu J.W., Zhang L.N., Zhang Z.H.: “RNA interference inhibits expression of cyclooxygenase-2 and matrix metalloproteinase-2 in rabbit corneal stromal cells”. Zhonghua Yan Ke Za Zhi, 2008, 44, 831.

[14] Lönnroth C., Andersson M., Arvidsson A., Nordgren S., Brevinge H., Lagerstedt K., et al.: “Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer”. Cancer Immun., 2008, 8, 5.

[15] Strillacci A., Griffoni C., Lazzarini G., Valerii M.C., Di Molfetta S., Rizzello F., et al.: “Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells”. Br. J. Cancer, 2010, 103, 975.

[16] Chan M.W., Wong C.Y., Cheng A.S., Chan V.Y., Chan K.K., To K.F., et al.: “Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells”. Oncol. Rep., 2007, 18, 1557.

[17] John-Aryankalayil M., Palayoor S.T., Cerna D., Falduto M.T., Magnuson S.R., Coleman C.N.: “NS-398, ibuprofen, and cyclooxygenase- 2 RNA interference produce significantly different gene expression profiles in prostate cancer cells”. Mol. Cancer Ther., 2009, 8, 261.

[18] Li W.Y., Wang H., Lai B.T., Yang X.H., Zhang C.Y.: “Effects of RNA interference of COX-2 gene expression on malignant proliferation of A549 cells in vitro”. Zhonghua Zhong Liu Za Zhi, 2007, 29, 904.

[19] Liu L.L., Lin L.R., Tong M.L., Fu Z.G., Liu G.L., Zheng W.H., et al.: Effects of silencing cyclooxygenase-2 expression via RNA interference on the tumorigenicity of the SMMC-7721 human hepatocarcinoma cell line. Oncol. Rep., 2012, 27, 1829.

[20] Wang Q., Li M., Wang Y., Zhang Y., Jin S., Xie G., et al.: “RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells”. Cancer Lett., 2008,269, 127.

[21] Yamazoe S., Tanaka H., Sawada T., Amano R., Yamada N., OhiraM., et al.: “RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells”. J. Exp. Clin. Cancer Res., 2010, 29, 53.